Mechanism of Growth Hormone Effects on Adipose Tissue
Completed · Phase 4
Conditions studied: Obesity
In brief
Growth hormone treatment in humans has been shown to decrease body fat. This study aims to determine what adipose tissue depots are affected by GH and what is the mechanism.
Key facts
- Study ID
- NCT00453557
- Run by
- Pennington Biomedical Research Center
- People needed
- 30
- Starts
- 1999-04-01
- Expected to finish
- 2000-12-01
- Last updated by the study team
- 2016-12-08
Who can join
Age: 40 and older, up to 70. Sex: male. Healthy volunteers: accepted.
You may qualify if…
- Male, aged 40-70
- Central obesity defined as waist circumference greater than 102 cm and BMI > 27 and < 35 kg/m2
- No weight loss in last 12 months
- Total IGF-1 level < 241 ng/ml (\~25th percentile for the assay)
- Body habitus which permitted accurate CT scan acquisition and analysis.
You may not qualify if…
- Significant neurologic, metabolic, endocrine, cardiac, respiratory or gastrointestinal disease
- Diabetes
- Known coronary heart disease
- Exercised more than 3 hours per week
- Unwilling or unable to abstain from alcohol for 72 hours prior to the measurements of energy expenditure and fasting blood work
Where it is running
- Pennington Biomedical Research Center — Baton Rouge, Louisiana, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.